NIH News Release
National Cancer Institute

Wednesday, April 11, 2001

NCI Press Office
(301) 496-6641

Note to Reporters and Editors:
National Cancer Institute Hosts Fifth International AIDS Malignancy
Conference with a Special Virology Component

What: National and international experts will meet at the National Institutes of Health (NIH) on April 23-25, 2001, to present new findings on the biology, epidemiology, and treatment of AIDS-related cancers, including Kaposi's sarcoma, lymphoma, and anal and cervical cancers. Sponsored by the National Cancer Institute (NCI), this annual meeting provides a state-of-the-art overview of knowledge about these malignancies, which have emerged as an epidemic within the larger AIDS epidemic.

This year's meeting includes a special virology component focusing on the viruses associated with AIDS-related cancers, including human herpesvirus 8, human papillomavirus, and Epstein-Barr virus. Presenters will discuss the latest information on mechanisms of viral oncogenesis and immune evasion, and on innovative approaches to treatment. Roundtables of experts will discuss the most recent data from a variety of pre-clinical animal models for AIDS cancers, advances in therapeutic and prophylactic vaccines for treatment and prevention of anogenital cancers, and ongoing and planned clinical trials from the AIDS Malignancy Consortium, a network of investigators across the United States conducting clinical trials for AIDS-related cancers. In addition, this meeting includes a new session focused on genomics, proteomics and bioinformatics.

When: Monday - Wednesday, April 23-25, 2001
8:30 a.m. - 5:00 p.m. EDT
Where: The meeting will take place at the Natcher Conference Center on the NIH campus in Bethesda, Md. For a detailed agenda, call the NCI Press Office at (301) 496-6641 or go to (click on AIDS Oncology Resources).

Parking on the NIH campus is extremely limited and all attendees are encouraged to use Metro.

The Natcher Center is conveniently located adjacent to the Medical Center station on Metro's Red Line.

Who: Featured Speakers:
Sara Rowland-Jones, D.M., John Radcliffe Hospital, U.K. Ian Frazer, M.D., University of Queensland, Australia
Lou Staudt, M.D., Ph.D., NCI
Riccardo Dalla Favera, M.D., Columbia University
Thomas Quinn, M.D., Johns Hopkins University/ NIAID
Anthony Nash, Ph.D., University of Edinburgh, Scotland